Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Return on Assets (2017 - 2025)

Historic Return on Assets for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to 2.1%.

  • Lexaria Bioscience's Return on Assets fell 13200.0% to 2.1% in Q4 2025 from the same period last year, while for Nov 2025 it was 2.1%, marking a year-over-year decrease of 13200.0%. This contributed to the annual value of 1.82% for FY2025, which is 8600.0% down from last year.
  • As of Q4 2025, Lexaria Bioscience's Return on Assets stood at 2.1%, which was down 13200.0% from 2.18% recorded in Q3 2025.
  • Lexaria Bioscience's Return on Assets' 5-year high stood at 0.0% during Q3 2021, with a 5-year trough of 2.18% in Q3 2025.
  • In the last 5 years, Lexaria Bioscience's Return on Assets had a median value of 0.85% in 2022 and averaged 0.97%.
  • As far as peak fluctuations go, Lexaria Bioscience's Return on Assets surged by 10900bps in 2024, and later crashed by -15500bps in 2025.
  • Lexaria Bioscience's Return on Assets (Quarter) stood at 0.16% in 2021, then plummeted by -467bps to 0.92% in 2022, then plummeted by -102bps to 1.85% in 2023, then surged by 58bps to 0.78% in 2024, then plummeted by -169bps to 2.1% in 2025.
  • Its last three reported values are 2.1% in Q4 2025, 2.18% for Q3 2025, and 1.48% during Q2 2025.